Question Bank › Deliberately different by design

Deliberately different by design

Deliberately different by design: management explains how the company operates unlike its industry's standard playbook,

Calls Tested
440
Answered YES
32
Hit Rate
7.3%
rare by design

Vanda Pharmaceuticals Inc. (VNDA) — this company's answers

NO on the Q4 2021 call 2022-02-23 F
The model's full reasoning — Q4 2021 call → NOWe need answer only YES or NO. Need analyze transcript. Management describes company as deliberately operating differently from standard way industry works? Need identify specific chosen difference in how company builds, sells, prices, serves, sources, staffs, organizes itself that departs from normal practice of competitors/industry, and credit that difference as real driver of business results right now. Transcript: Vanda Pharmaceuticals. Main discussion: tradipitant gastroparesis Phase III failed primary endpoint but they propose analytic approach to adjust for placebo response, baseline severity inflation. They claim industry/FDA standard trial designs are prone to placebo response, and they have developed an analysis approach that aims to reduce placebo effect. They intend to collaborate with FDA. Is this a "chosen departure from industry's normal way" in how company operates? They are proposing a different analytical approach to clinical trials, not necessarily a business model difference. They contrast with FDA guidance and standard clinical study designs. But is that a way the company builds/sells/prices/serves? It's about regulatory approval strategy. They say "We believe that the current clinical study designs required by the FDA for regulatory approval in gastroparesis are especially prone to large placebo responses... Vanda has developed an analysis approach..." This is a chosen difference in how they seek approval, not necessarily how they operate business. Also they credit it? They say "we believe evidence constitutes substantial evidence" but not current business results. They haven't gotten approval. It's not paying off in current real business. Also they discuss HETLIOZ payer challenges, SMS launch, etc. No deliberate operational difference. Need answer NO.

← Back to the full VNDA analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe the company as DELIBERATELY OPERATING DIFFERENTLY FROM THE STANDARD WAY ITS INDUSTRY WORKS — identifying a specific, chosen difference in how the company builds, sells, prices, serves, sources, staffs, or organizes itself that departs from what management presents as the normal practice of its competitors or industry — AND does management credit that chosen difference as a real driver of business results the company is achieving RIGHT NOW? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent posture with both halves present: (1) A NAMED, CHOSEN DEPARTURE FROM THE INDUSTRY'S NORMAL WAY. Management contrasts how this company operates with how the industry typically operates, and presents the difference as a deliberate design choice rather than an accident of size or circumstance. The difference may take whatever form fits the industry — for example: a different way of producing or delivering what others make conventionally; a different route to the customer than the industry standard; a different pricing, service, or ownership model than peers use; serving customers, regions, or work that the industry conventionally avoids or dismisses; keeping in-house what others outsource, or outsourcing what others keep; a different structure of assets, people, or process that management explains most competitors do not or will not replicate. What matters is that management itself draws the contrast — 'the industry does it this way; we chose to do it differently, and here is why' — in substance, even if not in those exact words. (2) THE DIFFERENCE IS PAYING OFF IN CURRENT, REAL BUSINESS. Management connects that chosen difference to concrete results already happening — customers won or kept, orders, volumes, margins, retention, speed, or access that the company is actually experiencing in the recent period because of how it operates — rather than to hoped-for future benefits. The connection should be management's own explanation of why the company is winning or performing now, grounded in present-tense business. Answer NO if management merely claims to be better, a leader, differentiated, or higher-quality without describing a specific chosen difference in HOW the company operates versus the industry's normal way. NO if the only difference described is being bigger, older, more experienced, or having more scale, locations, or resources of the same kind as peers. NO if the difference is only planned, aspirational, or newly announced with no current results credited to it. NO if the contrast with industry practice is drawn only by an analyst and not taken up by management. NO if the claimed difference is generic boilerplate ('our culture', 'our people', 'our customer focus') with no operational substance about what is actually done differently. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
TNET TriNet Group, Inc. Q1 2024 2024-04-26 C
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
PUMP ProPetro Holding Corp. Q4 2023 2024-02-21 C+
ACGL Arch Capital Group Ltd. Q4 2023 2024-02-15 B+
VIPS Vipshop Holdings Limited Q2 2023 2023-08-18 C+
PNNT PennantPark Investment Corporation Q3 2023 2023-08-10 B+
SITM SiTime Corporation Q2 2023 2023-08-02 C+
FTHM Fathom Holdings, Inc. Q1 2023 2023-05-10 C
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
M Macy's, Inc. Q4 2022 2023-03-02 D
TGT Target Corporation Q4 2022 2023-02-28 C
UAL United Airlines Holdings, Inc. Q4 2022 2023-01-18 B
ICL ICL Group Ltd Q3 2022 2022-11-09 B+
SYY Sysco Corporation Q1 2023 2022-11-01 C+
CMLS Cumulus Media Inc. Q3 2022 2022-10-28 D
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
WHF WhiteHorse Finance, Inc. Q1 2022 2022-05-10 B+
ZH Zhihu Inc. Q3 2021 2021-11-22 D
IRBT iRobot Corporation Q3 2021 2021-10-28 D
LPTH LightPath Technologies, Inc. Q4 2021 2021-09-09 D
TJX The TJX Companies, Inc. Q2 2021 2021-08-18 C
ORAN Orange SA Q2 2018 2018-07-26 B
ROP Roper Technologies, Inc. Q2 2018 2018-07-26 A
TOUR Tuniu Corporation Q4 2017 2018-03-14 D
TSLX Sixth Street Specialty Lending, Inc. Q4 2017 2018-02-22 C+
CCOI Cogent Communications Holdings, Inc. Q2 2017 2017-08-03 B
ABR Arbor Realty Trust, Inc. Q4 2016 2017-03-03 B+
PRI Primerica, Inc. Q3 2016 2016-11-10 B+
VRNS Varonis Systems, Inc. Q2 2016 2016-08-09 B+
RCL Royal Caribbean Cruises Ltd. Q1 2016 2016-04-29 C+
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C
SAN Banco Santander, S.A. Q4 2015 2016-01-27 B

How the model reasoned

ABR · Q4 2016 → YESThe question is: Does management describe the company as DELIBERATELY OPERATING DIFFERENTLY FROM THE STANDARD WAY ITS INDUSTRY WORKS, identifying a specific chosen difference, AND credit that as a dri...YES Management explicitly contrasts their approach with industry norms in two places. First, on the agency side they describe small-balance lending as “more difficult space operator in” and state they have “perfected our expertise” there, while noting that many other enterprises are restricted by caps on certain products and that their own business is 100% uncapped. Second, they present the combination of agency origination/servicing plus senior-debt balance-sheet lending as a deliberate, complementary platform that “will continue to enhance our originations platform, expand our market presence and broaden our products,” and they directly credit the agency platform’s growth (record $3.8 billion originations, 22 % increase, $13.6 billion servicing portfolio, 48 bp fee annuity) as the immediate driver of accretive core earnings, the dividend increase to $0.
KOPN · Q4 2023 → YESThe question is: Does management describe the company as DELIBERATELY OPERATING DIFFERENTLY FROM THE STANDARD WAY ITS INDUSTRY WORKS, identifying a specific chosen difference, AND credit that as a rea...YES Management explicitly describes its fab-light strategy as a deliberate departure from conventional industry practice (depositing OLED/microLEDs in China, which is not DoD-approved). They contrast this with the standard way competitors operate and credit the chosen difference with immediate business results: an early success factor is the European partner achieving superior 20,000 candela brightness at lower power, plus winning share from domestic competitors who are “struggling of late” and taking share of individual displays and optical solutions. They also tie the application-specific solution approach to current wins, such as delivering the CR3 module and recent contract awards.
SYY · Q1 2023 → YESThe question is: Does management describe the company as DELIBERATELY OPERATING DIFFERENTLY FROM THE STANDARD WAY ITS INDUSTRY WORKS, identifying a specific chosen difference, AND credit that as a rea...YES Management explicitly frames Sysco Your Way as a deliberate, chosen departure from the industry norm: it is a “next level of service” model built specifically for restaurant-dense neighborhoods, featuring late-evening order cutoffs, daily delivery, dedicated partner representation, and white-glove culinary/marketing support—elements they contrast with what they present as standard industry practice. They credit this difference with immediate, measurable results: “the top and bottom line results from the program are exceeding our expectations,” “winning substantial new customers,” and “existing customers are buying more product on a weekly basis.

More from the question bank

Buying its own future outputNumbers reset the ceilingCustomers eating the frictionWorking harder than they are being paid forOperating without a netMid-ramp quarter: contribution has started bAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.